Which of the following best describes the Therapeutic Confirmatory objectives?

• A. Refine understanding of benefit/risk in general or special populations; identify less common adverse reactions; refine dosing
• B. Demonstrate/confirm efficacy
• C. Explore use for targeted indication
• D. Develop marketing strategy and pricing

Answer: (A)

Therapeutic Confirmatory objectives are about solidifying the therapy’s benefit while thoroughly assessing safety and how the drug should be used across populations. These trials are designed to confirm efficacy and, importantly, to refine the overall benefit/risk profile by identifying less common adverse reactions and fine-tuning dosing in both general and special populations. This ensures the labeling accurately reflects who can benefit, how best to dose, and what rare or unexpected safety issues might arise, which is essential for regulatory approval.

Why the other ideas aren’t as complete: simply demonstrating efficacy misses the broader safety and dosing confirmation that those trials provide. Exploring use for a targeted indication fits more with exploratory or expansion activities, not the thorough confirmation of a broad, real-world benefit/risk profile. Marketing strategy and pricing are business considerations, not trial objectives.